Oral lichen planus (OLP) is a potentially malignant oral lesion that may transform into oral squamous cell carcinoma (OSCC). The purpose of this study was to assess the level of expression of MAPK/ERK1/2 gene, and microRNA (miR)-603, 4301, 8485, and 4731 in the MAPK signaling pathway in OLP and OSCC lesions. This case–control study evaluated 26 OSCC, 20 OLP and 20 healthy control tissue specimens. After RNA extraction, the respective miRNA and MAPK/ERK1/2 mRNA levels were assessed by quantitative reverse transcription polymerase chain reaction (RT-PCR). Significant upregulation of MAPK/ERK1/2 gene was noted in the OLP and OSCC specimens compared with healthy controls (p < 0.001). The expression level of miR-4731 was significantly lower in the OLP and OSCC specimens than in the healthy specimens (p < 0.001). The expression of MiR-603 was the lowest in OLP, followed by OSCC and then the control group (p < 0.001). No significant difference was found in miR-4801 levels between OSCC and OLP specimens compared with healthy controls (p = 0.43 and p = 0.86, respectively). In addition, a non-significant decrease in miR-8485 levels was noted in the OSCC and OLP specimens compared with healthy controls (p = 0.98 and p = 0.61, respectively). A significant decrease in level of miR-603 was noted in OLP compared with OSCC group (p < 0.001). The miR-4801 and miR-8485 expression levels were directly correlated with MAPK/ERK1/2 mRNA expression (p = 0.01). Higher expression level of MAPK/ERK1/2, miR-603, miR-4801, and miR-4731, and lower expression level of miR-8485 were correlated with significantly lower overall survival rate in OSCC patients. The increased expression of MAPK/ERK1/2 and decreased expression of miR-603 and miR-4731 are associated with greater risk of OLP malignant transformation and poor histopathological characteristics of OSCC.
This is a preview of subscription content, log in to check access.
Buy single article
Instant unlimited access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Najafi S, Gholizadeh N, Manifar S, Rajabzadeh S, Kharazi FM (2015) Salivary antioxidant level in oral squamous cell carcinoma. Iran J Blood Cancer 7:57–60
Gholizadeh N, Razavi HE, Haftkhani GJ, Sheykhbahaei N (2019) Predictive factors of survival rate in oral squamous cell carcinoma: a retrospective study in Iran. J Contemp Med Sci 5:101–105
Agha-Hosseini F, Sheykhbahaei N, SadrZadeh-Afshar M (2016) Evaluation of potential risk factors that contribute to malignant transformation of oral lichen planus: a literature review. J Contemp Dent Pract 17:692–701
Rupakar P, Kureshi A, Balar A, Khatri M, Parmar M, Pujara P et al (2016) Estimation of serum B2-microglobulin in oral precancerous lesions and oral squamous cell carcinoma. Natl J Integr Res Med 7:51–55
Aghbari SMH, Abushouk AI, Attia A, Elmaraezy A, Menshawy A, Ahmed MS et al (2017) Malignant transformation of oral lichen planus and oral lichenoid lesions: a meta-analysis of 20095 patient data. Oral Oncol 68:92–102
Van der Waal I (2014) Oral potentially malignant disorders: is malignant transformation predictable and preventable? Med Oral Patol Oral Cir Bucal 19:e386
Gholizadeh N, Poorfar HK, TaghaviZenouz A, Vatandoost M, Mehdipour M (2015) Comparison of serum autoantibodies to desmogleins I, III in patients with oral lichen planus and healthy controls. Iran J Pathol 10:136
Kumar SS, Zain RB (2018) Aetiology and risk factors for oral cancer–a brief overview. Ann Dent Univ Malaya 11:41–50
Morrison DK (2012) MAP kinase pathways. Cold Spring Harb Perspect Biol 4:a011254
Pierro C, Zhang X, Kankeu C, Trebak M, Bootman MD, Roderick HL (2018) Oncogenic KRAS suppresses store-operated Ca2+ entry and ICRAC through ERK pathway-dependent remodelling of STIM expression in colorectal cancer cell lines. Cell Calcium 72:70–80
Mayr D, Hirschmann A, Löhrs U, Diebold J (2006) KRAS and BRAF mutations in ovarian tumors: a comprehensive study of invasive carcinomas, borderline tumors and extraovarian implants. Gynecol Oncol 103:883–887
Cui X, Li S, Li T, Pang X, Zhang S, Jin J et al (2014) Significance of elevated ERK expression and its positive correlation with EGFR in Kazakh patients with esophageal squamous cell carcinoma. Int J Clin Exp Pathol 7:2382
Regalo G, Resende C, Wen X, Gomes B, Durães C, Seruca R et al (2010) C/EBPα expression is associated with homeostasis of the gastric epithelium and with gastric carcinogenesis. Lab Investig 90:1132
Pipan V, Zorc M, Kunej T (2015) MicroRNA polymorphisms in cancer: a literature analysis. Cancers (Basel) 7:1806–1814
Bayraktar R, Pichler M, Kanlikilicer P, Ivan C, Bayraktar E, Kahraman N et al (2017) MicroRNA 603 acts as a tumor suppressor and inhibits triple-negative breast cancer tumorigenesis by targeting elongation factor 2 kinase. Oncotarget 8:11641
Wang J, Luo H, Xiao Y, Wang L (2016) miR-125b inhibits keratinocyte proliferation and promotes keratinocyte apoptosis in oral lichen planus by targeting MMP-2 expression through PI3 K/Akt/mTOR pathway. Biomed Pharmacother 80:373–380
Aghbari SM, Zayed SO, Shaker OG, Abushouk AI (2019) Evaluating the role of tissue micro RNA-27b as a diagnostic marker for oral lichen planus and possible correlation with CD 8. J Oral Pathol Med 48:68–73
Aghbari SMH, Abushouk AI, Shakir OG, Zayed SO, Attia A (2018) Correlation between tissue expression of microRNA-137 and CD8 in oral lichen planus. Clin Oral Investig 22:1463–1467
Ahmadi-Motamayel F, Bayat Z, Hajilooi M, Shahryar-Hesami S, Mahdavinezhad A, Samie L et al (2017) Evaluation of the miRNA-146a and miRNA-155 expression levels in patients with oral lichen planus. Iran J Immunol 14:316–324
Ghallab NA, Kasem RF, El-Ghani SFA, Shaker OG (2017) Gene expression of miRNA-138 and cyclin D1 in oral lichen planus. Clin Oral Investig 21:2481–2491
Tao Y, Ai R, Hao Y, Jiang L, Dan H, Ji N et al (2019) Role of miR-155 in immune regulation and its relevance in oral lichen planus. Exp Ther Med 17:575–586
Danielsson K, Wahlin Y-B, Gu X, Boldrup L, Nylander K (2012) Altered expression of miR-21, miR-125b, and miR-203 indicates a role for these microRNAs in oral lichen planus. J Oral Pathol Med 41:90–95
Wang G, Zheng X, Zheng Y, Cao R, Zhang M, Sun Y et al (2019) Construction and analysis of the lncRNA-miRNA-mRNA network based on competitive endogenous RNA reveals functional genes in heart failure. Mol Med Rep 19:994–1003
Cheng J, Chen J, Wang Z, Yu D, Zu Y (2017) The functional role of microRNAs in laryngeal carcinoma. Open Life Sci 12:460–464
Ayaz L, Görür A, Yaroğlu HY, Özcan C, Tamer L (2013) Differential expression of microRNAs in plasma of patients with laryngeal squamous cell carcinoma: potential early-detection markers for laryngeal squamous cell carcinoma. J Cancer Res Clin Oncol 139:1499–1506
Scapoli L, Palmieri A, Muzio LL, Pezzetti F, Rubini C, Girardi A et al (2010) MicroRNA expression profiling of oral carcinoma identifies new markers of tumor progression. Int J Immunopathol Pharmacol 23:1229–1234
Lu J, Zhao J, Liu K, Zhao J, Yang H, Huang Y et al (2010) MAPK/ERK1/2 signaling mediates endothelial-like differentiation of immature DCs in the microenvironment of esophageal squamous cell carcinoma. Cell Mol Life Sci 67:2091–2106
Sasaki K, Hitora T, Nakamura O, Kono R, Yamamoto T (2011) The role of MAPK pathway in bone and soft tissue tumors. Anticancer Res 31:549–553
Nakanishi H, Taccioli C, Palatini J, Fernandez-Cymering C, Cui R, Kim T et al (2014) Loss of miR-125b-1 contributes to head and neck cancer development by dysregulating TACSTD2 and MAPK pathway. Oncogene 33:702
Yang X, Wu X (2016) miRNA expression profile of vulvar squamous cell carcinoma and identification of the oncogenic role of miR-590-5p. Oncol Rep 35:398–408
Ma C, Zhan C, Yuan H, Cui Y, Zhang Z (2016) MicroRNA-603 functions as an oncogene by suppressing BRCC2 protein translation in osteosarcoma. Oncol Rep 35:3257–3264
Stark MS, Klein K, Weide B, Haydu LE, Pflugfelder A, Tang YH et al (2015) The prognostic and predictive value of melanoma-related microRNAs using tissue and serum: a microRNA expression analysis. EBioMedicine 2:671–680
Stark MS, Tom LN, Boyle GM, Bonazzi VF, Soyer HP, Herington AC et al (2016) The ‘Melanoma-enriched’microRNA miR-4731-5p acts as a tumour suppressor. Oncotarget 7:49677
Hiraki M, Nishimura J, Takahashi H, Wu X, Takahashi Y, Miyo M et al (2015) Concurrent targeting of KRAS and AKT by MiR-4689 is a novel treatment against mutant KRAS colorectal cancer. Mol Ther-Nucleic Acids 4:e231
Fan Z, Chen X, Chen R (2014) Transcriptome-wide analysis of TDP-43 binding small RNAs identifies miR-NID1 (miR-8485), a novel miRNA that represses NRXN1 expression. Genomics 103:76–82
Kattimani Y, Veerappa AM (2018) Dysregulation of NRXN1 by mutant MIR8485 leads to calcium overload in pre-synapses inducing neurodegeneration in Multiple sclerosis. Mult Scler Relat Disord 22:153–156
Conflict of interest
The authors have no conflict of interest to declare.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Gholizadeh, N., Emami Razavi, A., Mohammadpour, H. et al. Association of MAPK and its regulatory miRNAs (603, 4301, 8485, and 4731) with the malignant transformation of oral lichen planus. Mol Biol Rep 47, 1223–1232 (2020) doi:10.1007/s11033-019-05223-6
- Oral lichen planus
- Oral squamous cell carcinoma